Prediction of Response to Recruitment Maneuvers in Patients With Acute Respiratory Failure
Launched by UNIVERSITÀ DEGLI STUDI DI FERRARA · Sep 15, 2016
Trial Information
Current as of May 22, 2025
Completed
Keywords
ClinConnect Summary
The investigators will monitor lung ventilation by EIT during the whole protocol and perform P-V curves and arterial blood gas analysis at every step of the protocol.
Participants will be sedated and paralyzed, ventilated in volume-controlled with protective ventilation (tidal volume=6-8 mL/Kg of predicted body weight and respiratory rate set to obtain normal pH) then the protocol will follow 5 steps each lasting 20 minutes to obtain clinical stability:
1. PEEP 5 centimeter of water (cmH2O)
2. PEEP 10 cmH2O
3. Recruitment maneuver followed by PEEP 15 cmH2O
4. PEEP 10 cmH2O
5. PEEP 5 cmH2O
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with acute hypoxemic respiratory failure defined by recent known clinical insult or worsening of respiratory symptoms and arterial pressure of oxygen to inspired fraction of oxygen ratio (PaO2/FiO2) ≤300 mmHg
- • Patient on invasive mechanical ventilation
- • Age ≥18 years
- • Written informed consent
- Exclusion Criteria:
- • Pregnancy
- • Unstable hemodynamic condition requiring blood transfusion or adjustment of inotropics more often than every hour
- • FiO2 ≥80% or clinical suspicion of pulmonary embolism
- • Pneumothorax
- • Chronic obstructive pulmonary disease (COPD) with clinical symptoms of lung emphysema as evidenced by chest radiography or computed tomography or autoPEEP \> 5 cmH2O
- • Intracranial hypertension
- • Impossibility to correctly position the EIT belt (e.g., dressings, chest drainage, etc.)
- • Contraindications to EIT (e.g., implantable cardiac defibrillator, pacemaker, instable spinal lesions)
About Università Degli Studi Di Ferrara
The Università degli Studi di Ferrara, a distinguished Italian institution, is dedicated to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university fosters innovative clinical trials aimed at enhancing patient care and treatment outcomes. Leveraging a robust network of researchers, clinicians, and academic partners, the university is committed to translating scientific discoveries into practical applications that address pressing healthcare challenges. Its focus on ethical standards and rigorous methodologies ensures high-quality research that contributes to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ferrara, , Italy
Patients applied
Trial Officials
Savino Spadaro, MD
Principal Investigator
Università degli Studi di Ferrara
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials